In order to provide α-substituted piperazines for early-stage medicinal chemistry studies, a simple, general synthetic approach is required. Here, we report the development of two general and simple procedures for the racemic lithiation/trapping of N-Boc piperazines. Optimum lithiation times have been determined using in situ IR spectroscopy and the previous complicated and diverse literature procedures have been simplified. Subsequent trapping with electrophiles delivered a wide range of α-functionalised N-Boc piperazines. The scope and limitations of the distal N-group has been investigated. The selective α-and β-arylation of N-Boc piperazines via lithiation/Negishi coupling is reported.
Figure 1. Structures of bio-active piperazines Indinavir and Vestipitant
The use of α-substituted piperazines in medicinal chemistry is somewhat limited by their poor commercial availability and the lack of simple methods for their synthesis. Available approaches include the formation of the piperazine ring, traditionally from amino acids (via ketopiperazines), 5 or more recently via Mitsunobu chemistry, 6 Pd-7 or Au-catalysis, 8 photoredox catalysis, 9 or Bode's SnAP 10 and SLAP 11 reagents. The direct functionalization of the intact piperazine ring is an alternative strategy, allowing late stage introduction of the α-substituent. As an example, photoredox catalysis has been used for direct α-arylation and vinylation of N-aryl substituted piperazines but is limited to N-aryl substituents. 12 In 2016, we reported a route to a wide range of α-substituted piperazines via the enantioselective α-lithiation/trapping of NBoc piperazines. 13, 14 Although this previous study focused on the arguably more challenging asymmetric reaction, there remains a need to explore conditions for racemic lithiation/trapping for the following reasons. First, earlystage medicinal chemistry studies require rapid access to racemic products. Second, the racemic and asymmetric reactions do not always behave analogously. Third, the racemic lithiation/trapping of N-Boc piperazines is relatively under investigated and the few reports 15 have significant variation in the conditions used, involving very different reaction times and temperatures (Scheme 1). For example, van Maarseveen's conditions involved multiple warm/cool cycles.
15a Subsequent reports by Coldham 15b and ourselves 15c employed either lengthy reaction times at -78 °C or short reaction times at elevated temperatures. Additional reports, focused on target synthesis, have used further modifications of these procedures.
15d-i
Scheme 1. Direct Functionalization of N-Boc Piperazines via Lithiation/Trapping
Due to the wide range of experimental conditions that have been reported to date and the need to have simple access to racemic products for medicinal chemistry studies, we set out to develop a general, unified and experimentally simple procedure for the direct functionalization of N-Boc piperazines via racemic lithiation/trapping (Scheme 1). Herein, we report our results and present two complementary, general procedures which were informed by in situ IR spectroscopic studies.
The simplest piperazine lithiation protocol involves the use of commercially available, orthogonally protected NBoc-N'-benzyl piperazine 1 and diamine-free lithiation conditions, carried out at easily manageable (on a research scale) cryogenic conditions (-78 °C). Additionally, in our hands, we found that performing the reactions at -78 °C gave more reproducible yields than when using our previously published high-temperature (-30 °C) lithiation conditions. 15c To assess the feasibility of such a system, we employed the use of in situ IR spectroscopy to identify the time taken for lithiation (by monitoring the change in ν C=O ). 16 A solution of 1 in THF at -78 °C showed a ν C=O peak at 1696 cm -1 . Upon addition of s-BuLi, lithiation of 1 proceeded to give lithiated intermediate 2 (ν C=O peak at 1645 cm -1 ) in 1 h (Scheme 2). In contrast to our previous in situ IR spectroscopic studies with s-BuLi/diamines in Et 2 O, the pre-lithiation species was not detected. Having determined the time required for the diaminefree lithiation of 1, the full lithiation/trapping process was investigated. Treatment of N-Boc-N'-benzyl piperazine 1 with 1.3 eq. of s-BuLi in THF at -78 °C for 1 h followed by addition of the electrophile gave α-substituted piperazines 3a-g in 44-90% yields (Scheme 3). Good yields (60-74%) were obtained with Me 3 SiCl, Bu 3 SnCl, MeI, methyl chloroformate and paraformaldehyde. The use of cyclohexanone and benzophenone gave oxazolidinones 3f and 3g in 44% and 90% respectively, after cyclisation of the intermediate alkoxide on to the Boc group. The low yield of 3f is probably due to the electrophile undergoing facile enolisation.
With an operationally simple lithiation/trapping procedure established, we chose to investigate the substrate scope and varied the expectedly innocuous distal Nsubstituent. Interestingly, our optimized diamine-free lithiation protocol gave varied results when applied to NBoc-N'-methyl piperazine 4. Lithiation under our standard conditions (s-BuLi, THF, -78 °C, 1 h) proceeded in the usual way, as shown by in situ IR monitoring (see Supporting Information) However, trapping with Me 3 SiCl gave no α-silylated piperazine 6 (Scheme 4). The only product observed by 1 H NMR spectroscopy was the ring fragmented side-product 5, which was isolated in 30% yield. As reported in our study into the asymmetric lithiation/trapping of N-Boc piperazines, 13 this side-product is formed by attack of the distal nitrogen on the electrophile, followed by ring fragmentation and N-Si bond cleavage upon work-up. Likewise, trapping with methyl chloroformate gave ring fragmented side-products 7 and 8 in 34% and 11% yields respectively. The latter formed from a subsequent Boc-directed vinylic lithiation (and trapping) event. In contrast, trapping with benzophenone gave α-substituted products 9 and 10 in 83% and 12% yields with no evidence of ring fragmented side-products. We suggest that ketones are less likely to interact with the distal nitrogen lone pair than Me 3 SiCl and methyl chloroformate and so ring fragmentation did not occur. 15a To verify whether their low yield was in fact due to ring fragmentation, we repeated van Maarseveen's experiment. In our hands, none of the desired product 6 was formed and the only fragmentation side-products 5 (isolated in 37% yield) and vinyl silane 11 (isolated in 32%) were observed (Scheme 5).
Scheme 5. Explanation of the Failure of the Lithiation/Trapping of 4 with Me 3 SiCl
Thus, the use of a small distal N-substituent led to limitations with some electrophiles (Me 3 SiCl and methyl chloroformate) due to ring fragmentation. In contrast increasing the size of the group led to a pronounced reduction in the rate of lithiation. Initial in situ IR studies with the previously reported 14,15b N-Boc-N'-tert-butyl piperazine 12 showed that diamine-free lithiation was much slower than with N-Boc-N'-benzyl piperazine 1. 13 17 within 15 min (Scheme 6).
Scheme 6. In situ IR Spectroscopic Monitoring of the Lithiation of N-Boc Piperazine 12
Due to the shorter lithiation time and associated operational ease, we opted to perform lithiation/trapping reactions of the sterically hindered N-Boc-N'-tert-butyl piperazine 12 and N-Boc-N'-cumyl piperazine 16 using sBuLi/TMEDA in Et 2 O at -78 °C for 1 h. Exposure of either 12 or 16 to these conditions followed by trapping led to α-substituted piperazines 17 and 18 in 45-98% yields (Scheme 7). Since we were unsuccessful in our attempts to cleave the N-tert-butyl group we focused mostly on cumyl protected piperazine 16 as it can be removed by hydrogenolysis. 13 Silylated, stannylated and methylated piperazines 18a, 18b and 18c were isolated in 98%, 80% and 95% yield respectively. Transmetallation to copper followed by trapping with allyl bromide 15a,17 gave α-allyl piperazine 18d in 80% yield. Lithiation/trapping of 16 and 12 with methyl chloroformate resulted in methyl esters 18e and 17a in 66% and 45% yields. Trapping 16 with paraformaldehyde gave a mixture of oxazolidinone 18f and alcohol 18g in 26% and 57% yield. Use of cyclohexanone gave solely oxazolidinone 18h in 58% yield. Trapping of 16 with benzophenone gave 18i and 18j in a total yield of 97%, whereas trapping of 12 gave only oxazolidinone 17b in 57% yield. Importantly, no ring fragmented side-products were observed in any case (due to the sterically demanding N-substituent), and the cumyl protecting group can be easily removed by hydrogenolysis. 13 Interestingly, for the same electrophile, the yields with N-Boc-N'-cumyl piperazine 16 (Scheme 7) were higher than when using N-Boc-N'-benzyl piperazine 1 (Scheme 3). It is possible that the larger protecting group prevents unwanted coordination of the distal nitrogen to the electrophiles. One of the most useful extensions to the lithiation/trapping of N-Boc heterocycles for synthetic applications is the α-arylation methodology developed by Campos and co-workers. 18 This process proceeds via Li/Zn transmetallation and subsequent Negishi cross-coupling and has been well studied using N-Boc pyrrolidine 19 and piperidine. 16b,20 In 2010, our group reported the only example with an N-Boc piperazine.
15c Therefore we decided to explore the arylation reaction using our diamine free conditions, since TMEDA was known to hinder the Negishi coupling. 
Scheme 8. Arylation of N-Boc piperazines 1 and 16
Submitting N-Boc-N'-cumyl piperazine 16 to arylation catalyzed by Pd(dba) 2 and RuPhos resulted in formation of only the α-arylated piperazine 21 in 15% yield, along with ring-fragmentation side-product 22 which was isolated in 30% yield (Scheme 8). Thus, selective synthesis of both the α-and β-arylated piperazines can be achieved through substrate control by varying the distal nitrogen protecting group and catalyst system. These initial preliminary results are encouraging and could warrant further investigation.
In conclusion, we have developed unifying, simple and general procedures for the racemic lithiation/trapping of N-Boc piperazines. In situ IR spectroscopic methods were used to determine the optimum conditions for lithiation of substrates with both sterically small (benzyl) and large (cumyl) substituents. The previous complicated and diverse literature procedures have been simplified, resulting an easy diamine-free lithiation/trapping of N-Boc-Nbenzyl piperazine 1 and a slightly more complicated but higher yielding lithiation/trapping of N-Boc-N-cumyl piperazine 16. These methods represent much needed simple and general approaches for the direct racemic functionalization of piperazines, and will find use in earlystage medicinal chemistry programmes. Additionally, the selective formation of both α-and β-arylated piperazines has been discovered.
Experimental Section
All-non aqueous reactions were carried out under oxygen free Ar or N 2 using flame-dried glassware. Et 2 O and THF were freshly distilled from sodium and benzophenone.
Alkyllithiums were titrated against Nbenzylbenzamide before use. TMEDA was distilled over CaH 2 before use. Petrol refers to the fraction of petroleum ether boiling in the range 40-60 °C and was purchased in Winchester quantities. Water is distilled water.
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-440 mesh). Thin layer chromatography was carried out using commercially available Merck F 254 aluminium backed silica plates. Proton (400 MHz) and carbon (100.6 MHz) NMR spectra were recorded on a Jeol ECX-400 instrument using an internal deuterium lock. For samples recorded in CDCl 3 , chemical shifts are quoted in parts per million relative to CHCl 3 (δ H 7.26) and CDCl 3 (δ C 77.0, central line of triplet). Carbon NMR spectra were recorded with broad band proton decoupling and assigned using DEPT experiments. Coupling constants (J) are quoted in Hertz. Melting points were carried out on a Gallenkamp melting point apparatus. Boiling points give for compounds purified by Kügelrohr distillation correspond to the oven temperature during distillation. Infrared spectra were recorded on an ATI Mattson Genesis FT-IR spectrometer or a Perkin Elmer UATR Two FT-IR spectrometer. Electrospray high and low resonance mass spectra were recorded at room temperature on a Bruker Daltronics microOTOF spectrometer. In situ ReactIR ™ infra-red spectroscopic monitoring was performed on a Mettler-Toledo ReactIR iC10 spectrometer with a silicon-tipped (SiComp) probe.
Diamine Free Lithiation/Trapping of N-Boc-N'-Benzyl Piperazine 1. s-BuLi (1.3 M solution in hexanes, 1.3 eq.) was added dropwise to a stirred solution of N-Boc-N'-Benzyl Piperazine 1 (1.0-3.0 mmol, 1.0 eq.) in THF (0.14 M) at -78 °C under Ar. The resulting solution was stirred at -78 °C for 1 h. Then the electrophile (2.0 eq.) was added dropwise, as a solution in THF (1 mL) if necessary. The reaction mixture was stirred at -78 °C for 15 min and then allowed to warm to rt over 30 min. Then, saturated NH 4 Cl (aq) (10 mL), 20% NaOH (aq) (10 mL) and Et 2 O (10 mL) were added and the two layers were separated. The aqueous layer was extracted with Et 2 O (3 × 10 mL). The combined organic layers were dried (MgSO 4 ), filtered and evaporated under reduced pressure to give the crude product which was purified by flash column chromatography on silica gel.
tert-Butyl
4-benzyl-2-(trimethylsilyl)piperazine-1-carboxylate (3a). N-Boc-N'-benzyl piperazine 1 (276 mg, 1.0 mmol), s-BuLi (1.3 M solution in hexanes, 1.0 mL, 1.3 mmol) and Me 3 SiCl (254 µL, 2.0 mmol) gave, after purification (SiO 2 , 9:1 petrol-EtOAc), substituted piperazine 3a (236 mg, 68%) as a colourless oil; R F (9:1 petrol-EtOAc) 0. tert-Butyl 4-methylpiperazine-1-carboxylate (4). A solution of di-tert-butyl dicarbonate (21.6 g, 99.2 mmol, 1.1 eq.) in CH 2 Cl 2 (50 mL) was added dropwise to a stirred solution of N-methyl piperazine (10 mL, 90.2 mmol, 1.0 eq.) in CH 2 Cl 2 (150 mL) at 0 °C under Ar. The resulting solution was allowed to warm to rt and stirred for at rt for 16 h. Water (100 mL) and 20% NaOH (aq) (100 mL) were added and the layers separated. The aqueous layer was extracted with CH 2 Cl 2 (3 × 100 mL). The combined organic layers were dried (MgSO 4 ), filtered and evaporated under reduced pressure to give the crude product. Purification by Kugelrohr distillation gave N-Boc-N′-methyl piperazine 4 ( °C, stirred for 1 h then allowed to warm to rt over 16 h. Then, saturated NH 4 Cl (aq) (10 mL) and 20% NaOH (aq) (10 mL) were added and the two layers were separated. The aqueous layer was extracted with Et 2 O (3 × 10 mL). The combined organic layers were dried (MgSO 4 TMEDA mediated lithiation/trapping of N-Boc-N'-tert-butyl piperazine 12 and N-Boc-N'-cumyl piperazine 16. s-BuLi (1.3 M solution in hexanes, 1.3 eq.) was added dropwise to a stirred solution of N-Boc piperazine (0.5-1.0 mmol, 1.0 eq.) and TMEDA (1.3 eq.) in Et 2 O (0.14 M) at -78 °C under Ar. The resulting solution was stirred at -78 °C for 1 h. Then the electrophile (2.0 eq.) was added dropwise, as a solution in THF (1 mL) if necessary. The reaction mixture was stirred at -78 °C for 15 min and then allowed to warm to rt over 30 min. Then, saturated NH 4 Cl (aq) (10 mL), 20% NaOH (aq) (10 mL) and Et 2 O (10 mL) were added and the two layers were separated. The aqueous layer was extracted with Et 2 O (3 × 10 mL). The combined organic layers were dried (MgSO 4 ), filtered and evaporated under reduced pressure to give the crude product which was purified by flash column chromatography on silica gel. 126.3, 126.0, 116.8, 79.3, 59.4, 52.0 (br), 48.0, 46.4, 39.6 (br),  34.5, 28.4, 24.5, 23.2; IR (CHCl 3 ) 2972, 2930, 2776, 1658  (C=O), 1397, 1344, 1305, 1197, 1153, 1092, 972, 950, 907, 761 47 (m, 2H), 7.35-7.29 (m, 2H), 7.26-7.20  (m, 1H), 4.32 (t, J = 8.0 Hz, 1H), 3.88-3.72 (m, 3H) substituted piperazine 18j, (55 mg, 23%) as a white solid, R F (7:3 petrol-EtOAc) 0.2; mp 54-56 °C; 1 09 (m, 1H), 1.32 (s, 1.5H), 1.29 (s, 1.5H),  1.24 (s, 1.5H), 1.22 (s, 4.5H), 1.16 (s, 1.5H 
tert-Butyl N-ethenyl-N-[2-(methylamino)ethyl]carbamate (5). N-Boc-N'-methyl

tert-Butyl
zine 18b (260 mg, 81%) as a colourless oil; R F (19:1 petrolEtOAc) 0.3; 1 H NMR (400 MHz, CDCl 3 ) (50:50 mixture of rotamers) δ 7.49 (d, J = 7.5 Hz, 2H), 7.29 (t, J = 7.5 Hz
